Robotics Events Calendar

Event Information

Anjan Nan, PhD, from the Department of Pharmaceutical Sciences, is slated to give a lecture on Nanotechnology and Drug Delivery on Monday, February 11, 2013, from 2-3pm at FDAs White Oak location.

Abstract: Recent advances in nanotechnology have made available structures with controlled properties in the nanometer size range. Nanomaterials are similar in size to many functional biomolecules which makes them biologically useful. By controlling structure at the nanoscale, one can tailor properties to better suit integration with biological systems. Nanoscale structures have found applications in a wide range of areas including research enablers, biosensing, imaging and targeted drug delivery. The focus of this lecture will be on recent advances in the design and development of novel nanostructures for biomedical applications. Emphasis will be placed in the area of targeted delivery of bioactive and imaging agents. Examples of nanoconstructs to be discussed include water-soluble polymer therapeutics, dendrimers and inorganic engineered nanostructures such as gold nanoparticles and silica nanotubes. Examples of research conducted at the Center for Nanomedicine and Cellular Delivery at the University of Maryland will be presented with special emphasis on how physicochemical properties of nanomaterials influence their biological interactions such as biodistribution, transport, uptake and toxicity.

Bio: Dr Anjan Nan, PhD, is Assistant Professor of Pharmaceutical Sciences at the University of Maryland, as well as co-Director of the Center for Nanomedicine and Cellular Delivery. He obtained a BS in Pharmaceutical Sciences from Jadavpur University and a PhD in Pharmaceutics from the University of Mississippi. He was a Research Assistant Professor at the University of Maryland, prior to his current appointment. His research interests are in the design and development of nanocarriers for drug delivery and imaging applications, with special interest in water-soluble polymer-drug conjugates for targeted cancer therapy, as well as engineered inorganic silica nanotubes for image guided biomolecule delivery.